The tumor status of TP53 is largely ignored in the clinical management of patients with breast cancers, although decades of research clearly implicate p53 in the response to DNA damage through multiple mechanisms including a direct interaction with DNA repair machinery15. Here, TP53 is linked to neoplasm.